These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7861580)

  • 41. What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications.
    Kallenberg CG; Tervaert JW
    Curr Opin Nephrol Hypertens; 1999 May; 8(3):307-15. PubMed ID: 10456261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige J; Pollock W; Trevisin M
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
    Simon A; Subra JF; Guilpain P; Jeannin P; Pignon P; Blanchard S; Garo E; Jaillon S; Chevailler A; Renier G; Puéchal X; Bottazzi B; Mantovani A; Delneste Y; Augusto JF
    PLoS One; 2016; 11(1):e0147091. PubMed ID: 26797217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of anti-neutrophil cytoplasmic autoantibodies in the diagnosis of Wegener's granulomatosis].
    Zielonka TM; Samoliński B; Tchórzewska H; Chorzelski T; Droszcz W
    Pol Arch Med Wewn; 1991 Aug; 86(2):113-6. PubMed ID: 1775389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Rapidly progressive glomerulonephritis without immune deposits: detection of neutrophil anticytoplasmic antibodies].
    Castillo A; Valderrama G; Ardiles L; Caorsi I; Mezzano S
    Rev Med Chil; 1993 Mar; 121(3):260-4. PubMed ID: 8248637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct differences in autoantigen specificity of anti-neutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases.
    Wiik A; Brimnes J; Heegaard NH
    Isr Med Assoc J; 1999 Sep; 1(1):4-7. PubMed ID: 11370121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antineutrophil cytoplasmic antibodies (ANCA).
    Radice A; Sinico RA
    Autoimmunity; 2005 Feb; 38(1):93-103. PubMed ID: 15804710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ANCA-associated vasculitides. Immunological and clinical aspects. Proceedings of the 4th International Workshop on ANCA and the 2nd International Colloquium on Wegener's Granulomatosis and Vasculitic Disorders. May 28-30, 1992, Lübeck, Germany.
    Adv Exp Med Biol; 1993; 336():1-549. PubMed ID: 8296595
    [No Abstract]   [Full Text] [Related]  

  • 51. Anti-neutrophil cytoplasmic antibodies tests: which tests should be used in practice?
    Wiik A
    Intern Med; 2001 Jun; 40(6):466-70. PubMed ID: 11446667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Detection of anti-neutrophil cytoplasmic antibodies with proteinase 3 specificity by immunoblotting].
    Chevailler A; Taouil K; Carrère F; Renier G; Hurez D
    Pathol Biol (Paris); 1994 Jun; 42(6):575-80. PubMed ID: 7854857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Anti-neutrophil cytoplasmic autoantibody (ANCA) in systemic vasculitic syndrome].
    Arimura Y; Nagasawa T
    Rinsho Byori; 1993 Aug; 41(8):866-75. PubMed ID: 8371502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
    Kallenberg CG; Heeringa P; Stegeman CA
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-carbonic anhydrase III autoantibodies in vasculitis syndrome.
    Saito R; Watanabe H; Asano T; Suzuki E; Iwadate H; Kobayashi H; Ohira H
    Int J Rheum Dis; 2013 Jun; 16(3):339-46. PubMed ID: 23981757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antineutrophil cytoplasmic autoantibodies (ANCA) associated vasculitides--immunologic and clinical aspects.
    Schulz JI
    Bratisl Lek Listy; 1995 Oct; 96(10):520-2. PubMed ID: 8620321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops.
    Savige JA; Davies DJ; Gatenby PA
    Pathology; 1994 Apr; 26(2):186-93. PubMed ID: 8090592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presenting features in Pakistani patients suffering from the antineutrophil cytoplasmic antibody--classical subtype (c-ANCA) associated vasculitis.
    Ahmed TA; Halim A; Farooqi A; Hussain T; Ikram N; Qureshi M; Moin S; Shafique H; Ali L; Malik J; Karamat KA
    J Pak Med Assoc; 1999 Mar; 49(3):54-6. PubMed ID: 10531780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Wegener's granulomatosis and ANCA-associated vasculitis: pathogenic role of autoantigens, autoantibodies, and cytokines].
    Kekow J; Csernok E; Szymkowiak CH; Gross WL
    Immun Infekt; 1993 Apr; 21 Suppl 1():44-8. PubMed ID: 8344692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.